Recently, Parker McCollum's son Major received an intimate show from his dad during tummy time. In a video shared to social media, McCollum sits on the floor next to Major, who is sprawled out on ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023.

Zion Williamson and C.J. McCollum are set to remain in New Orleans past Thursday's trade deadline, according to NBA insider Marc J. Spears. NBA on ESPN @ESPNNBA "Zion Williamson and C.J. McCollum ...

Many fans know Parker McCollum as a top-notch country singer and songwriter. However, he has a more important job these days—raising his son Major. When he’s not out on the road or in the ...

Behind the Numbers preview for #Pelicans second straight game in Denver at 8 p.m. CT (Trey Murphy one of only three New Orleans players to appear in all three games vs. Nuggets; CJ McCollum adds ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

7:26 PM A veteran team might view McCollum as a valuable scoring option in the playoffs, but his name hasn’t come up often in rumors around the league, partially because of his $30.6 million ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the details for Canadian investors. Canada Goose Holdings Inc.’s third ...

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving ...